By rray, 14 June, 2024 Exclude Patient Type Detail Header No Detail Type Text Detail Text FHx of breast or ovarian CA or other hereditary breast and ovarian syndrome assoc CA e g prostate pancreatic Known deleterious gene mutation Prior breast bx w specific pathology nbsp nbsp Atypical hyperplasia lobular or ductal nbsp nbsp Lobular carcinoma in situ Early menarche Late menopause Nulliparity lower parity Prolonged interval between menarche and first pregnancy Older age at first live birth Menopausal hormone tx w estrogen and progestin decreased risk w estrogen alone Current or prior estrogen and progesterone hormone agent IUD excepted Not breastfeeding Advancing age Certain ethnicities e g increased risk of BRCA mutation in Ashkenazi Jewish women Higher BMI Alcohol consumption Smoking Dense breasts on mammography Prior exposure to high dose therapeutic chest irradiation in young women 10 30 yo Self 1st deg relative w Li Fraumeni Cowden BRR syndromes Personal hx of ovarian pancreatic or early onset breast CA Ethnicity race further studies needed on social determinants of health and existing health care disparities to clarify Patient Type Detail Header (Long) <b>Risk factors:</b><sup>2,4,6</sup>